Pregled bibliografske jedinice broj: 330086
House dust mite immunotherapy increased transforming growth factor-beta1-producing T cells in asthmatic children
House dust mite immunotherapy increased transforming growth factor-beta1-producing T cells in asthmatic children // Abstracts "World Immune Regulation Meeting" / Akdis, Cezmi (ur.).
Davos, 2007. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 330086 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
House dust mite immunotherapy increased transforming growth factor-beta1-producing T cells in asthmatic children
Autori
Ajduk, Jakov ; Marinić, Igor ; Aberle, Neda ; Rabatić, Sabina ; Gagro, Alenka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts "World Immune Regulation Meeting"
/ Akdis, Cezmi - Davos, 2007
Skup
World Immune Regulation Meeting
Mjesto i datum
Davos, Švicarska, 11.04.2007. - 15.04.2007
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
children; asthma; allergy; immunotherapy; intracellular staining; flow cytometry
Sažetak
Recent evidence suggests that regulatory T cells and immunosuppressive cytokines such as TGF-beta1 and IL-10 may have a role in clinically effective allergen-specific immunotherapy (SIT). Our objective was to study the frequency of regulatory T cells and expression of molecules associated with their functions (CTLA-4, TGF-beta1 and IL-10) in samples obtained from children allergic to house dust mite (HDM) during subcutaneous allergen SIT. In this uncontrolled open-label study, peripheral blood mononuclear cells were obtained from 16 children allergic to house dust mite before and at 3 and 12 months of SIT, and from 10 healthy children. The percentage of CD4+ regulatory T cells (CD69-CD45RO+CTLA-4+ and CD3+CD4+CD25+FOXP3+ markers) and production of IL-10 and TGF-beta1 were analyzed by flow cytometry. Clinical parameters such as symptom score, medication requirements, FEV1, PEFR, and serum IgE were also determined. All clinical parameters improved during immunotherapy. The percentage of CD4+CD25+CD69-CD45RO+ regulatory T cells remained unchanged. CTLA-4+ expressing regulatory T cells transiently increased after three months of immunotherapy, while the percentage of CD3+CD4+CD25+FOXP3+ cells did not change after one year of immunotherapy initiation. TGF-beta1 positive cells increased during immunotherapy and IL-10 positive cells transiently decreased after three months of immunotherapy. In conclusion, clinically effective subcutaneous HDM specific immunotherapy in children was accompanied by an increased number of TGF-beta1 positive T cells and transient increase in the proportion of CTLA-4+ regulatory T cells. The percentage of IL-10 positive T cells transiently decreased after three months of SIT, which is inconsistent with some previous studies conducted in adults. The results allow us to conclude that although regulatory T cells and immunosuppressive cytokines TGF-beta1 and IL-10 play a significant role in the mechanism of antigen-specific immunotherapy, they are poor marker of SIT efficacy.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
021-0212432-2439 - Mehanizmi urođene imunosti u infekciji respiracijskim sincicijskim virusom (RSV) (Rabatić, Sabina, MZOS ) ( CroRIS)
072-1080229-0337 - Modulacija funkcije ljudskih regulacijskih T-limfocita (Gagro, Alenka, MZOS ) ( CroRIS)
219-0620228-2058 - Utjecaj genetičkih i okolišnih činitelja na razvoj astme u djece (Miškić, Blaženka, MZOS ) ( CroRIS)
Ustanove:
Imunološki zavod d.d.,
Opća bolnica "Dr. Josip Benčević"
Profili:
Jakov Ajduk
(autor)
Neda Aberle
(autor)
Alenka Gagro
(autor)
Sabina Rabatić
(autor)
Igor Marinić
(autor)